Aurobindo Pharma reported INR580.8M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Cipla INR 807.77M 807.43M Sep/2025
Divis Laboratories Ltd INR 265.47M 264.53M Sep/2025
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Hindustan Unilever INR 2.35B 409K Sep/2025
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
UPL INR 843.31M 746.69M Sep/2025